Nicola Groth – Biography

Last update: April 9, 2026

Executive profile

Nicola was Head Safety Evaluation & Risk Management Italy at GSK Vaccines, and Global Head, Clinical Trial Serious Adverse Event Management at Novartis. Nicola Groth joined Osivax in 2024.

Nicola Groth is currently

Chief Medical Officer at Osivax - View - Osivax org chart



Create your alert
to follow the career of Nicola Groth.

Education

Nicola Groth has a PhD in Medicine from University of Siena.

More about Nicola Groth

The colleagues of Nicola Groth

Company Colleagues
Industry Colleagues
  • In the Biotechnology industry, Nicola Groth has 35,756 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.

Report an error
Update the org chart details of Nicola Groth.

Get in Touch

Here are a few tips for establishing great contacts.

Through the switchboard, call Osivax at +33 97... and ask for Nicola Groth.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.